только для медицинских специалистов
Консультант врача. Электронная медицинская библиотека

Консультант врача

Электронная медицинская библиотека

Доступ к библиотеке Версия для слабовидящих
Раздел 4 / 10
Страница 1 / 1

Список литературы

  1. Давыдов М.И. (ed.). Энциклопедия клинической онкологии: М.; РЛС, 2004. – 834 с.
  2. d’Errico A., Pasian S., Baratti A. et al. A case-controlled study on occupational risk factors for sino-nasal cancer. Occup Environ Med 2009;66:448–55.
  3. Benninger M.S. The impact of cigarette smoking and environmental tobacco smoke on nasal and sinus disease: a review of the literature. Am J Rhinol 1999;13(6):435–8.
  4. Каприн А.Д., Старинский В.В., Петрова Г.В. (eds.). Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М.; МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2017. – С. 11, 15, 16.
  5. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Ethmoid Sinus Tumors. Maxillary Sinus Tumors Version 3.2019.
  6. De Bondt, R. B. J., Nelemans, P. J., Hofman, P. A. M., et al. (2007). Detection of lymph node metastases in head and neck cancer: A meta-analysis comparing US, USgFNAC, CT and MR imaging. European Journal of Radiology, 64(2), 266–272
  7. Fleming A.J. Jr., Smith S.P. Jr., Paul C.M. et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007;117:1173–9
  8. Nandwana,U.Verma,M.Soni,T.P et al. (2018).Survival Impact of Postoperative Adjuvant Radiotherapy for Treatment of Advanced Stage Maxillary Sinus Cancer Patients, 12(2), XC01- XC03
  9. Hoppe B.S., Nelson C.J., Gomez D.R. et al. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008;72:763–9
  10. Schantz SP, Harrison LBForastiere AA Tumors of the nasal cavity and paranasal sinuses. De Vita Jr VTHellman SRosenberg SA Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia, PA Lippincott Williams & Wilkins2001;819- 824
  11. Стандарты лучевой терапии. Каприн А.Д., Костин А.А., Хмелевский Е.В. (eds.). М.: ГЭОТАР‑Медиа, 2019. – С. 15–35
  12. Болотина Л. В., Владимирова Л. Ю., Деньгина Н. В., Новик А. В., Романов И. С. Практические рекомендации по лечению злокачественных опухолей головы и шеи // Злокачественные опухоли: Практические рекомендации RUSSCO #3s2, 2018 (том 8). С. 71– 82
  13. Jacobs, C., Lyman, G., Velez-García, E. et al (1992). A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 10(2), 257–263
  14. Péron, J., Polivka, V., Chabaud, S., et al. (2014). An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents. BMC Cancer, 14(1)
  15. Zenda, S., Onozawa, Y., Boku, N., Iida, Y., Ebihara, M., & Onitsuka, T. (2007). Single-agent Docetaxel in Patients with Platinum-refractory Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN). Japanese Journal of Clinical Oncology, 37(7), 477– 481
  16. Vermorken J.B., Trigo J., Hitt R. et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum- based therapy. J Clin Oncol 2007;25:2171–7
  17. Болотина Л.В., Владимирова Л.Ю., Деньгина Н.В., Новик А.В., Романов И.С. Практические рекомендации по лечению злокачественных опухолей головы и шеи. Злокачественные опухоли : Практические рекомендации RUSSCO #3s2, 2019 (том 9). С. 81–94
  18. Logemann J.A., Pauloski B.R., et al. Speech and Swallowing Rehabilitation for Head and Neck Cancer Patients. ONCOLOGY 11(5):651-659,1997
  19. Сытов А. В., Лейдерман И. Н., Ломидзе С. В., Нехаев И. В., Хотеев А. Ж. Практические рекомендации по нутритивной поддержке онкологических больных // Злокачественные опухоли: Практические рекомендации RUSSCO #3s2, 2018 (том 8). С. 575–583
  20. Zhao, S. G., Alexander, N. B., Djuric, Z., et al (2015). Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trial. Head & Neck, 38(S1), E1086– E1096
  21. Segal R., Zwaal C., Green E. et al. Exercise for people with cancer: a systematic review. Curr Oncol. 2017 Aug; 24(4): e290–e31
  22. Samuel S.R., Maiya G.A., Fernandes D.J. et al. Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo- radiotherapy. Support Care Cancer 2019
  23. Mustian K.M., Alfano C.M., Heckler C. et al: Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017;3:961–8
  24. Kinkead B., Schettler P.J., Larson E.R. et al. Massage therapy decreases cancer-related fatigue: results from a randomized early phase trial. Cancer 2018;124(3):546–54
  25. Streckmann F., Zopf E.M., Lehmann H.C. et al: Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 2014;44:1289–304
  26. Lee J.M., Look R.M., Turner C. et al. Low-level laser therapy for chemotherapy-induced peripheral neuropathy. J Clin Oncol 2012;30(15):9019
  27. Rick O., von Hehn U., Mikus E. et al. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: a prospective randomized placebo–controlled phase-III study. Bioelectromagnetics 2016:38(2):85–94
  28. Oberoi S., Zamperlini-Netto G., Beyene J. et al. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 2014;9(9):e107418
  29. He M., Zhang B., Shen N., Wu N., Sun J. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur J Pediatr 2018;177(1):7–17
  30. Ross M., Fischer-Cartlidge E. Scalp cooling: a literature review of efficacy, safety, and tolerability for chemotherapy-induced alopecia. Clin J Oncol Nurs 2017;21(2):226–33
  31. Avci P., Gupta G.K., Clark J. et al. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med 2013;46(2):144–51
  32. Bensadoun R.J., Nair R.G. Low-level laser therapy in the management of mucositis and dermatitis induced by cancer therapy. Photomed Laser Surg 2015;33(10):487–91

Для продолжения работы требуется вход / регистрация